Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2010 | 04-2009 | 04-2008 | 04-2007 | 04-2006 | |
| Sales | 47 | 0 | 0 | 0 | 0 |
| Cost of Goods | 39 | N/A | N/A | N/A | N/A |
| Gross Profit | 8 | N/A | N/A | N/A | N/A |
| Operating Expenses | 10,249 | 8,601 | 2,965 | 1,772 | 4,135 |
| Operating Income | -10,202 | -8,601 | -2,965 | -1,772 | -4,135 |
| Interest Expense | 155 | 24,856 | 3,612 | 1,679 | 1,656 |
| Other Income | -151 | 239 | -145 | 120 | 1,724 |
| Pre-tax Income | -10,507 | -33,219 | -6,721 | -3,331 | -4,067 |
| Net Income Continuous | -10,507 | -33,219 | -6,721 | -3,331 | -4,067 |
| Net Income | $-10,507 | $-33,219 | $-6,721 | $-3,331 | $-4,067 |
| EPS Basic Total Ops | -0.54 | -2.88 | -0.05 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.54 | -2.88 | -0.05 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.54 | -2.88 | -0.08 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.54 | -2.88 | -0.03 | -0.02 | -0.03 |
| EBITDA(a) | $-10,091 | $-8,581 | $-2,862 | $-1,620 | $-2,215 |